Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02840032

Determination of Pneumothorax Post Lung Biopsy

Role of Ultrasonography in the Diagnosis of Pneumothorax Following Transbronchial Biopsy in LungTransplant Patients.

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Bedside ultrasonography for detection of pneumothorax after transbronchial lung biopsies in lung transplant patients

Detailed description

The patients who undergo transbronchial forceps lung biopsies get a routine CXR after the biopsies are performed. The reason for CXR is to find out if pneumothorax occurred or not. CXR is required patient transportation and interpretation by the radiologist as well as time consuming. Instead, we are planning to perform bedside ultrasound to determine if pneumothorax occurred or not

Conditions

Timeline

Start date
2016-07-01
Primary completion
2017-08-01
Completion
2017-08-01
First posted
2016-07-21
Last updated
2018-05-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02840032. Inclusion in this directory is not an endorsement.